Detalles de la búsqueda
1.
Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(1): 88-99, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30509771
2.
Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 849-56, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686957
3.
Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial.
Lancet
; 387(10021): 857-65, 2016 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-26686960
4.
Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04.
Ann Surg
; 261(1): 144-8, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24670844
5.
Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients.
Oncologist
; 19(5): 492-7, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24710310
6.
Breast Cancer Index and Prediction of Extended Aromatase Inhibitor Therapy Benefit in Hormone Receptor-Positive Breast Cancer from the NRG Oncology/NSABP B-42 Trial.
Clin Cancer Res
; 30(9): 1984-1991, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376912
7.
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphoma.
Blood
; 118(15): 4053-61, 2011 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-21673350
8.
Ten-year update: NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer.
J Natl Cancer Inst
; 115(11): 1302-1309, 2023 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37184928
9.
Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1.
Cancer
; 118(20): 5171-8, 2012 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22415454
10.
Induction versus no induction chemotherapy before neoadjuvant chemoradiotherapy and surgery in oesophageal adenocarcinoma: a multicentre randomised phase II trial (NCCTG N0849 [Alliance]).
Eur J Cancer
; 150: 214-223, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33934058
11.
Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA.
Support Care Cancer
; 18(2): 179-87, 2010 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-19415341
12.
Phase III randomized, double-blind study of maintenance CAI or placebo in patients with advanced non-small cell lung cancer (NSCLC) after completion of initial therapy (NCCTG 97-24-51).
Lung Cancer
; 60(2): 200-7, 2008 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-18045731
13.
Randomized Phase II Trial of Fulvestrant Plus Everolimus or Placebo in Postmenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer Resistant to Aromatase Inhibitor Therapy: Results of PrE0102.
J Clin Oncol
; 36(16): 1556-1563, 2018 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29664714
14.
Phase I North Central Cancer Treatment Group Trial-N9923 of escalating doses of twice-daily thoracic radiation therapy with amifostine and with alternating chemotherapy in limited stage small-cell lung cancer.
Int J Radiat Oncol Biol Phys
; 67(4): 995-1001, 2007 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-17336213
15.
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
Leuk Lymphoma
; 48(7): 1290-8, 2007 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-17613756
16.
Topotecan is an active agent in the first-line treatment of metastatic or recurrent endometrial carcinoma: Eastern Cooperative Oncology Group Study E3E93.
J Clin Oncol
; 21(11): 2110-4, 2003 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12775736
17.
Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy.
Pain
; 98(1-2): 195-203, 2002 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-12098632
18.
Evidence of cellular immune activation in children with opsoclonus-myoclonus: cerebrospinal fluid neopterin.
J Child Neurol
; 19(12): 919-24, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15704863
19.
Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer.
Pharmacoeconomics
; 32(12): 1231-43, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25154747
20.
Capecitabine and oxaliplatin in the preoperative multimodality treatment of rectal cancer: surgical end points from National Surgical Adjuvant Breast and Bowel Project trial R-04.
J Clin Oncol
; 32(18): 1927-34, 2014 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24799484